|
|
Article: FibroGen Closes $56.5 Million Private Financing; Japanese, Finnish and U.S. Investors Led by Franklin Templeton and American Express Financial Advisors.
- Article from:
- Business Wire
- Article date:
- September 28, 2000
CopyrightCOPYRIGHT 2000 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors and Health/Medical Writers
SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--Sept. 28, 2000
FibroGen, Inc., announced today the completion of a $56.5 million private placement of convertible preferred stock. Investors, including a syndicate representing Finland, Japan, Taiwan, and current FibroGen stockholders, were led in the financing by Franklin Templeton Investments and American Express Financial Advisors (AMEX).
"The success of this financing allows FibroGen the opportunity to aggressively expand activities manufacturing scale up and commercialization of our synthetic collagens and gelatin and to accelerate the research and ...